The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

An expert panel was convened in October 2013 by the International Scientific Association for Probiotics and Prebiotics (ISAPP) to discuss the field of probiotics. It is now 13 years since the definition of probiotics and 12 years after guidelines were published for regulators, scientists and industry by the Food and Agriculture Organization of the United Nations and the WHO (FAO/WHO). The FAO/WHO definition of a probiotic—“live microorganisms which when administered in adequate amounts confer a health benefit on the host”—was reinforced as relevant and sufficiently accommodating for current and anticipated applications. However, inconsistencies between the FAO/WHO Expert Consultation Report and the FAO/WHO Guidelines were clarified to take into account advances in science and applications. A more precise use of the term 'probiotic' will be useful to guide clinicians and consumers in differentiating the diverse products on the market. This document represents the conclusions of the ISAPP consensus meeting on the appropriate use and scope of the term probiotic.

[1]  G. Gloor,et al.  A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. , 2012, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[2]  C. Childs,et al.  Modulation of vaccine response by concomitant probiotic administration , 2013, British journal of clinical pharmacology.

[3]  A. Saggioro Probiotics in The Treatment of Irritable Bowel Syndrome , 2004, Journal of clinical gastroenterology.

[4]  I. Liljefors [Vitamin C and the common cold]. , 1972, Lakartidningen.

[5]  P. Calder,et al.  Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. , 2009, Current pharmaceutical design.

[6]  M. de Vrese,et al.  Probiotics--compensation for lactase insufficiency. , 2001, The American journal of clinical nutrition.

[7]  F. Bäckhed,et al.  Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. , 2012, Cell host & microbe.

[8]  C. Grangette,et al.  Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide , 2011, Gut.

[9]  Marcus Zulian Teixeira The hygiene hypothesis revisited , 2005, Homeopathy.

[10]  E. Zoetendal,et al.  Duodenal infusion of donor feces for recurrent Clostridium difficile. , 2013, The New England journal of medicine.

[11]  Ateequr Rehman,et al.  Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. , 2011, Gastroenterology.

[12]  Gregor Reid,et al.  Microbiology: Categorize probiotics to speed research , 2012, Nature.

[13]  H. van Loveren,et al.  Health claims in Europe: probiotics and prebiotics as case examples. , 2012, Annual review of food science and technology.

[14]  Guillermo Bernaola Aponte,et al.  Probiotics for treating persistent diarrhoea in children. , 2010, The Cochrane database of systematic reviews.

[15]  H. Hemilä Vitamin C and Common Cold Incidence: A Review of Studies with Subjects Under Heavy Physical Stress , 1996, International journal of sports medicine.

[16]  G. Donelli,et al.  Probiotics and clinical effects: is the number what counts? , 2013, Journal of chemotherapy.

[17]  T. Winzenberg,et al.  Vitamin D supplementation for improving bone mineral density in children. , 2010, The Cochrane database of systematic reviews.

[18]  F. Guarner,et al.  Should yoghurt cultures be considered probiotic? , 2005, British Journal of Nutrition.

[19]  H. Sokol,et al.  Faecalibacterium prausnitzii and human intestinal health. , 2013, Current opinion in microbiology.

[20]  R. Knight,et al.  Moving pictures of the human microbiome , 2011, Genome Biology.

[21]  Nayoung Kim,et al.  World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. , 2012, Journal of clinical gastroenterology.

[22]  M. Kleerebezem,et al.  Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways , 2010, Proceedings of the National Academy of Sciences.

[23]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[24]  G. Gloor,et al.  Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut , 2013, Microbiome.

[25]  S. E. Gad,et al.  Generally Recognized as Safe (GRAS) , 2014 .

[26]  Harri Hemilä,et al.  Vitamin C for Preventing and Treating the Common Cold , 2005, PLoS medicine.

[27]  J. Meigs,et al.  Yogurt consumption is associated with better diet quality and metabolic profile in American men and women. , 2013, Nutrition research.

[28]  M. Nieuwdorp,et al.  Probiotics and prebiotics: prospects for public health and nutritional recommendations , 2014, Annals of the New York Academy of Sciences.

[29]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[30]  F. Guarner,et al.  Mechanisms of Disease: the hygiene hypothesis revisited , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[31]  L. Qin,et al.  Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies , 2011, European Journal of Clinical Nutrition.

[32]  D. Mozaffarian,et al.  Changes in diet and lifestyle and long-term weight gain in women and men. , 2011, The New England journal of medicine.

[33]  G. Guyatt,et al.  Probiotics for the Prevention of Clostridium difficile–Associated Diarrhea , 2012, Annals of Internal Medicine.

[34]  Taixiang Wu,et al.  Probiotics for preventing acute upper respiratory tract infections , 2015, The Cochrane database of systematic reviews.

[35]  G. Gloor,et al.  Microbial ecosystems therapeutics: a new paradigm in medicine? , 2013, Beneficial microbes.

[36]  M. Sanders How Do We Know When Something Called "Probiotic" Is Really a Probiotic? A Guideline for Consumers and Health Care Professionals , 2009 .

[37]  J. Gern,et al.  The hygiene hypothesis revisited. , 2005, Immunology and allergy clinics of North America.

[38]  G. Guyatt,et al.  The GRADE approach and Bradford Hill's criteria for causation , 2010, Journal of Epidemiology & Community Health.

[39]  G. Gibson,et al.  The Health Benefits of Probiotics and Prebiotics , 2008 .

[40]  M. Blaser,et al.  Infant antibiotic exposures and early-life body mass , 2013, International Journal of Obesity.

[41]  G. Guyatt,et al.  Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. , 2013, The Cochrane database of systematic reviews.

[42]  E. Zoetendal,et al.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. , 2012, Gastroenterology.

[43]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[44]  Efsa Panel on Dietetic Products Scientific Opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 , 2010 .

[45]  Henrik Svanström,et al.  Antibiotic use and inflammatory bowel diseases in childhood , 2010, Gut.

[46]  A. Schuchat DEPARTMENT OF HEALTH & HUMAN SERVICES , 2015 .

[47]  R. Berg,et al.  A Systematic Review and Meta-analysis , 2010 .

[48]  M. Blaser,et al.  What are the consequences of the disappearing human microbiota? , 2009, Nature Reviews Microbiology.

[49]  Lucie Geurts,et al.  Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity , 2013, Proceedings of the National Academy of Sciences.

[50]  M. Hattori,et al.  Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota , 2013, Nature.

[51]  P. Whorwell,et al.  Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide , 2013, Alimentary pharmacology & therapeutics.

[52]  Birbal Singh,et al.  Probiotic metabolites as epigenetic targets in the prevention of colon cancer. , 2013, Nutrition reviews.

[53]  R. Knight,et al.  Microbiota restoration: natural and supplemented recovery of human microbial communities , 2011, Nature Reviews Microbiology.

[54]  Marcus J Claesson,et al.  An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota , 2011, Gut.

[55]  J. Geleijnse,et al.  Consumption of dairy products and associations with incident diabetes, CHD and mortality in the Whitehall II study. , 2013, The British journal of nutrition.

[56]  C. Grangette,et al.  Mechanisms Involved in Alleviation of Intestinal Inflammation by Bifidobacterium Breve Soluble Factors , 2009, PloS one.

[57]  C. Fraser,et al.  Probiotics: Finding the Right Regulatory Balance , 2013, Science.

[58]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[59]  T. Romanuk,et al.  A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases , 2012, PloS one.

[60]  Rafael Perera,et al.  A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome , 2009, BMC gastroenterology.

[61]  Stephen Allen,et al.  Probiotics for treating acute infectious diarrhoea , 2011 .

[62]  Sebastian Tims,et al.  Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. , 2011, Gastroenterology.

[63]  Max Nieuwdorp,et al.  Therapeutic potential of fecal microbiota transplantation. , 2013, Gastroenterology.

[64]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[65]  C. Gahan,et al.  The gut microbiota and the metabolic health of the host , 2014, Current opinion in gastroenterology.

[66]  H. Flint,et al.  Understanding the effects of diet on bacterial metabolism in the large intestine , 2007, Journal of applied microbiology.

[67]  Francisco Guarner,et al.  The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.

[68]  Susanne Hempel,et al.  Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. , 2012, JAMA.

[69]  J. Geleijnse,et al.  Dairy product intake in relation to glucose regulation indices and risk of type 2 diabetes. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[70]  D. Bassler,et al.  Probiotics for prevention of necrotizing enterocolitis in preterm infants (Review) , 2014 .

[71]  D. van der A,et al.  The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study. , 2012, The American journal of clinical nutrition.

[72]  Feng Liu,et al.  A systematic review and meta-analysis 2 , 2015 .

[73]  S. Salminen,et al.  Yoghurt and probiotic bacteria in dietary guidelines of the member states of the European Union. , 2014, Beneficial microbes.